Literature DB >> 3491093

Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.

H Akiyama, D Sinha, F S Seaman, E P Kirby, P N Walsh.   

Abstract

The interaction of Factor XIIa with Factor XI was investigated using two monoclonal antibodies, one (3Cl) directed against the heavy chain of Factor XIa and the other (5F4) against its light chain. 3C1 either as intact IgG or as Fab' fragment, enhanced the rate of Factor XIa generation in the fluid phase but inhibited it in the presence of kaolin and high molecular weight (HMW) kininogen. In contrast, the Fab' fragments of 5F4 inhibited only the fluid phase activation and had no effect on the surface-mediated activation. 3C1 was found to block the binding of Factor XI to HMW kininogen, whereas 5F4 did not. We conclude: a domain on the heavy chain region of Factor XI is essential for binding to HMW kininogen and for optimal surface-mediated activation by Factor XIIa; and binding of 3C1 to Factor XI changes its conformation rendering it a more favorable substrate for Factor XIIa in the fluid phase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491093      PMCID: PMC423936          DOI: 10.1172/JCI112756

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.

Authors:  S G IATRIDIS; J H FERGUSON
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.

Authors:  B N Bouma; J H Griffin
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

4.  Association of factor XI and high molecular weight kininogen in human plasma.

Authors:  R E Thompson; R Mandle; A P Kaplan
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

5.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

Review 6.  The biology and pathology of the initial stages of blood coagulation.

Authors:  O D Ratnoff
Journal:  Prog Hematol       Date:  1966

7.  Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor).

Authors:  K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

8.  Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.

Authors:  R J Mandle; R W Colman; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

9.  Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.

Authors:  J H Griffin; C G Cochrane
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.